Medicare Enrolled
Dr. Bibas Reddy, D.O.
Hematology & Oncology · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Bibas Reddy is a hematology & oncology specialist in Fort Worth, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 54,029 Medicare services across 1,555 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $14,097 from 54 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 17% volume in TX
$14,097 industry payments
Medicare Practice Summary
Medicare Utilization ↗54,029
Medicare services
Top 17% in TX for hematology & oncology
1,555
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,002 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
27,961 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
15,900 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,302 | $0 | $5 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,780 | $1 | $52 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,760 | $6 | $28 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
489 | $12 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
456 | $94 | $275 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
298 | $138 | $350 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
294 | $101 | $412 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
273 | $2 | $20 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
247 | $2 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $63 | $175 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
202 | $2 | $60 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
188 | $11 | $60 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
158 | $57 | $401 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
155 | $22 | $100 |
| COVID-19 test, self-administered An FDA-approved, authorized, or cleared test kit for nonprescription self-administered and self-collected use. This code represents the provision of one test count. |
152 | $12 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
125 | $1 | $10 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
110 | $1 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
90 | $21 | $93 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
88 | $47 | $190 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
80 | $162 | $681 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
79 | $49 | $202 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
74 | $48 | $160 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
71 | $93 | $250 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
64 | $15 | $60 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
51 | $83 | $399 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
51 | $1,108 | $4,069 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 44 | $101 | $450 |
| New patient office visit, complex (60-74 min) | 43 | $164 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $62 | $175 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
39 | $1 | $5 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
23 | $26 | $155 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
20 | $37 | $120 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
18 | $158 | $785 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
18 | $48 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
16 | $65 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $135 | $500 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
11 | $14 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
96.0% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,097
Total received (2018-2024)
Avg $2,014/year across 7 years
Top 26% in TX for hematology & oncology
54
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,418 (38.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,994 (35.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,685 (26.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,853
2023
$5,826
2022
$335
2021
$1,607
2020
$2,542
2019
$685
2018
$1,249
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novocure Inc.
$4,693
AstraZeneca Pharmaceuticals LP
$3,824
Celgene Corporation
$348
Takeda Pharmaceuticals U.S.A., Inc.
$323
E.R. Squibb & Sons, L.L.C.
$302
Lilly USA, LLC
$278
Sirtex Medical Inc
$258
Puma Biotechnology, Inc.
$233
GlaxoSmithKline, LLC.
$226
Janssen Biotech, Inc.
$220
Merck Sharp & Dohme Corporation
$214
Clovis Oncology, Inc.
$189
Ipsen Biopharmaceuticals, Inc
$176
Stemline Therapeutics Inc.
$163
Tempus AI, Inc
$159
Foundation Medicine, Inc.
$144
Novartis Pharmaceuticals Corporation
$141
Eisai Inc.
$138
Incyte Corporation
$138
PUMA BIOTECHNOLOGY, INC.
$136
Monteris Medical Corporation
$135
Melinta Therapeutics, LLC
$124
Blueprint Medicines Corporation
$119
Daiichi Sankyo Inc.
$115
AbbVie, Inc.
$110
Regeneron Pharmaceuticals, Inc.
$104
Amgen Inc.
$97
Teva Pharmaceuticals USA, Inc.
$92
Merck Sharp & Dohme LLC
$77
Gilead Sciences, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$68
SANOFI-AVENTIS U.S. LLC
$65
TG THERAPEUTICS, INC.
$50
Kite Pharma, Inc.
$50
ARRAY BIOPHARMA INC
$49
ABBVIE INC.
$46
Astellas Pharma US Inc
$42
Exelixis Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
GENZYME CORPORATION
$33
Epizyme, Inc.,
$31
Bayer HealthCare Pharmaceuticals Inc.
$28
Karyopharm Therapeutics Inc.
$27
Acrotech Biopharma LLC
$26
Genmab U.S., Inc.
$23
PFIZER INC.
$22
Genentech USA, Inc.
$18
Alexion Pharmaceuticals, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
EMD Serono, Inc.
$15
MENARINI SILICON BIOSYSTEMS, INC.
$15
Seattle Genetics, Inc.
$15
MorphoSys, US Inc.
$14
Tactile Systems Technology Inc
$14
Top 3 companies account for 62.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Abraxane · Avastin · BELEODAQ · BENDEKA · Bavencio · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · ELAHERE · ELITEK · ENHERTU · ERBITUX · ERLEADA · Enhertu · Erleada · FLEXITOUCH · FRUZAQLA · GILOTRIF · IMFINZI · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nerlynx · Neulasta · Neuroblate · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · Optune · Orserdu · PLUVICTO · Padcev · Pomalyst · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezzayo · Rubraca · SANCUSO · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · Stivarga · TAGRISSO · TAXOTERE · TAZVERIK · Tivdak · UKONIQ · VELCADE · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XPOVIO · XTANDI · Xtandi · Yescarta · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (38%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $26 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
47
Per 100K population
2.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with mixed engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Reddy performed 27,961 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $14,097 from 54 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other hematology & oncology specialists in Fort Worth?
Dr. Reddy's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fort Worth
Browse hematology & oncology specialists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology